Biocorp Production Balance Sheet Health
Financial Health criteria checks 3/6
Biocorp Production has a total shareholder equity of €2.5M and total debt of €5.8M, which brings its debt-to-equity ratio to 234.8%. Its total assets and total liabilities are €12.6M and €10.1M respectively.
Key information
234.8%
Debt to equity ratio
€5.78m
Debt
| Interest coverage ratio | n/a |
| Cash | €2.67m |
| Equity | €2.46m |
| Total liabilities | €10.12m |
| Total assets | €12.58m |
Recent financial health updates
Recent updates
Would Biocorp Production (EPA:ALCOR) Be Better Off With Less Debt?
Dec 08
What Does The Future Hold For Biocorp Production (EPA:ALCOR)? These Analysts Have Been Cutting Their Estimates
Jun 26Biocorp Production (EPA:ALCOR) Just Reported And Analysts Have Been Cutting Their Estimates
Apr 11What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?
Mar 04Is Biocorp Production's (EPA:ALCOR) Share Price Gain Of 179% Well Earned?
Jan 10
What Type Of Shareholders Own The Most Number of Biocorp Production (EPA:ALCOR) Shares?
Nov 18Financial Position Analysis
Short Term Liabilities: ALCOR's short term assets (€8.6M) exceed its short term liabilities (€5.8M).
Long Term Liabilities: ALCOR's short term assets (€8.6M) exceed its long term liabilities (€4.4M).
Debt to Equity History and Analysis
Debt Level: ALCOR's net debt to equity ratio (126.3%) is considered high.
Reducing Debt: ALCOR's debt to equity ratio has reduced from 798.9% to 234.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ALCOR has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ALCOR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.